Results 301 to 310 of about 390,020 (313)
Some of the next articles are maybe not open access.
PI3Kγ inhibition: towards an 'aspirin of the 21st century'?
Nature Reviews Drug Discovery, 2006Thomas Ruckle +2 more
exaly
Development of PI3K inhibitors: lessons learned from early clinical trials
Nature Reviews Clinical Oncology, 2013Jordi Rodón +2 more
exaly
PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside
Seminars in Cancer Biology, 2019Ali S Alzahrani
exaly
Phosphatidylinositol 3 kinase (PI3K) inhibitors as new weapon to combat cancer
European Journal of Medicinal Chemistry, 2019Deena S Lasheen, Khaled A M Abouzid
exaly
Structural Determinants of Isoform Selectivity in PI3K Inhibitors
Biomolecules, 2019Michelle S Miller +2 more
exaly

